跳转至内容
Merck
CN

SAB4200685

Anti-Glucagon antibody, Mouse monoclonal

clone K79bB10, purified from hybridoma cell culture

别名:

Monoclonal Anti-Glucagon antibody produced in mouse, GCG, GLP1, GLP2, GRPP

登录 查看组织和合同定价。

选择尺寸

关于此项目

NACRES:
NA.41
UNSPSC Code:
51111800

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Anti-Glucagon antibody, Mouse monoclonal, clone K79bB10, purified from hybridoma cell culture

biological source

mouse

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

K79bB10, monoclonal

form

buffered aqueous solution

species reactivity

cat, rabbit, mouse, guinea pig, rat, dog, porcine, zebrafish, human

packaging

antibody small pack of 25 μL

concentration

~1 mg/mL

technique(s)

immunohistochemistry: 5-10 μg/mL using heat−retrieved formalin-fixed, paraffin-embedded Rat pancreas sections and Biotin/ExtrAvidin®-Peroxidase staining system.
radioimmunoassay: suitable

isotype

IgG1

shipped in

dry ice

storage temp.

−20°C

target post-translational modification

unmodified

Quality Level

200

Gene Information

cat ... Gcg(101097825)
dog ... Gcg(403571)
guinea pig ... Gcg(100135526)
human ... GCG(2641)
mouse ... Gcg(14526)
pig ... Gcg(397595)
rabbit ... Gcg(100341777)
rat ... Gcg(24952)

Application

Monoclonal Anti-Glucagon antibody produced in mouse has been used in immunofluorescence staining. The product may be used in several immunochemical techniques including immunohistochemistry and radioimmunoassay (RIA).

Biochem/physiol Actions

The biological activities of pancreatic glucagon include glycogenolysis, lipolysis, gluconeogenesis and ketogenesis. Glucagon has an antagonistic effect in the maintenance of normoglycemia to those of insulin and is suppressed by GLP1. Thus up-regulation of glucagon is leading to increased blood glucose levels. Glucagon-specific antibodies would prove useful as a Langerhans islets α cell, glucagonomas and tumor markers applying immunohistochemical techniques, and as an analytical tool in quantification of the hormone.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

Glucagon is a hormone peptide produced in Langerhans islets α-cells in the pancreas. The active form of glucagon is derived from the cleavage of preproglucagon (GCG). Additional cleavage peptides are oxyntomodulin and glucagon-like peptide-1 (GLP1).

Immunogen

Polymerized porcine glucagon

Physical form

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.

Legal Information

ExtrAvidin is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到合适的产品？  

试试我们的产品选型工具.

存储类别

12 - Non Combustible Liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

常规特殊物品
常规特殊物品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
0000490146
0000490145
0000490145
0000490146
0000467693

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Pancreatic regulation of glucose homeostasis
Roder PV, et al.
Experimental & Molecular Medicine, 48(3), e219-e219 (2016)
Abhishek A Kulkarni et al.
Oxidative medicine and cellular longevity, 2018, 1324739-1324739 (2018-05-23)
It is well known that a chronic state of elevated reactive oxygen species (ROS) in pancreatic β-cells impairs their ability to release insulin in response to elevated plasma glucose. Moreover, at its extreme, unmitigated ROS drives regulated cell death. This
An In Vivo Zebrafish Model for Interrogating ROS-Mediated Pancreatic
Kulkarni AA, et al.
Oxidative Medicine and Cellular Longevity, 2018 (2018)
Qingsheng Liu et al.
Advanced materials (Deerfield Beach, Fla.), 33(39), e2102852-e2102852 (2021-08-08)
Encapsulation of insulin-producing cells is a promising strategy for treatment of type 1 diabetes. However, engineering an encapsulation device that is both safe (i.e., no cell escape and no breakage) and functional (i.e., low foreign-body response (FBR) and high mass
The role of glucagon on type 2 diabetes at a glance
Godoy-Matos AF, et al.
Diabetology & Metabolic Syndrome, 6 (2014)
查看所有相关文献

相关内容

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持